Specific risks of liver transplantation in patients co-infected with hepatitis C virus and human immunodeficiency virus
Dumortier, J.ér.ôm.; Chiarello, P.; Adham, M.; Delafosse, B.; Chayvialle, J.-A.; Scoazec, J.-Y.; Boillot, O.
Gastroenterologie Clinique et Biologique 26(11): 1061-1062
2002
ISSN/ISBN: 0399-8320 PMID: 12483148 Document Number: 546223
Document emailed within 1 workday
Related Documents
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528Iroezindu, M.O.; Daniyam, C.A.; Agbaji, O.O.; Isa, E.S.; Okeke, E.N.; Imade, G.E. 2013: Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria Journal of Infection in Developing Countries 7(12): 951-959
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
Lecot, C.; Jeantils, V.; Ovaguimian, L.; Krivitzky, A.; Bréchot, C.; Dény, P. 1993: Polymerase chain reaction-based detection of hepatitis D virus RNA in patients infected with human immunodeficiency virus Progress in Clinical and Biological Research 382: 329-335
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Diaz, A.; Ten, A.; Marcos, H.; Gutiérrez, G.; González-García, J.; Moreno, S.; Barrios, A.M.ía.; Arponen, S.; Portillo, Ál.; Serrano, R.; García, M.T.; Pérez, J.é L.; Toledo, J.; Royo, M.C.; González, G.; Izquierdo, A.; Viloria, L.J.; López, I.; Elizalde, L.áz.; Martínez, E.; Castrillejo, D.; Aranguren, R.; Redondo, C.; Diez, M. 2015: Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus Enfermedades Infecciosas y Microbiologia Clinica 33(5): 324-330
Chasela, C.S.; Wall, P.; Drobeniuc, J.; King, C.C.; Teshale, E.; Hosseinipour, M.C.; Ellington, S.R.; Codd, M.; Jamieson, D.J.; Knight, R.J.; Fitzpatrick, P.; Kourtis, A.P.; Hoffman, I.F.; Kayira, D.; Mumba, N.; Kamwendo, D.D.; Martinson, F.; Powderly, W.; van der Horst, C.; Kamili, S.; Adair, L.; Ahmed, Y.; Ait-Khaled, M.; Albrecht, S.; Bangdiwala, S.; Bayer, R.; Bentley, M.; Bramson, B.; Bobrow, E.; Boyle, N.; Butera, S.; Chasela, C.; Chavula, C.; Chimerang'ambe, J.; Chigwenembe, M.; Chikasema, M.; Chikhungu, N.; Chilongozi, D.; Chiudzu, G.; Chome, L.; Cole, A.; Corbett, A.; Corneli, A.; Dow, A.; Duerr, A.; Eliya, H.; Ellington, S.; Eron, J.; Farr, S.; Ferguson, Y.O.; Fiscus, S.; Flax, V.; Fokar, A.; Galvin, S.; Guay, L.; Heilig, C.; Hoff 2012: Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 54(4): 318-320
Ramos Paesa, C.; Arazo Garcés, P.; Pascual Catalán, A.; Hermida Lazcano, I.; Aguirre Errasti, J.M. 1998: Characteristics of chronic hepatitis C in patients infected by human immunodeficiency virus Revista Clinica Espanola 198(4): 207-211
Begovac, J.; Romih, V. 2009: Treatment of chronic hepatitis C in human immunodeficiency virus infected patients Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 63(5): 423-429
Rebbani, K.; Ouladlahsen, A.; Bensghir, A.; Akil, A.; Lamdini, H.; Issouf, H.; Brahim, I.; Kitab, B.; Fakhir, F.Z.; Wakrim, L.; Marhoum El Filali, K.; Himmich, H.; Ezzikouri, S.; Benjelloun, S. 2013: Co-infections with hepatitis B and C viruses in human immunodeficiency virus-infected patients in Morocco Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 19(10): E454-E457
Jensen, D.M.; Peterson, D.A.; Wolfe, L.G.; Hurley, T.; Payne, J.A.; Ogden, J. 1984: Antibodies directed against human liver specific membrane lipoprotein (LSP) in marmosets experimentally infected with the hepatitis a virus Clinical and Experimental Immunology 55(3): 535-540
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
Mayor, A.M.; Gomez, M.A.; Fernandez, D.M.; Rios-Olivares, E.; Thomas, J.C.; Hunter, R.F. 2006: Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection American Journal of Tropical Medicine and Hygiene 74(2): 239-245
Subauste, C.S.; Wessendarp, M.; Portilllo, J-Andres.C.; Andrade, R.M.; Hinds, L.M.; Gomez, F.J.; Smulian, A.George.; Grubbs, P.A.; Haglund, L.A. 2004: Pathogen-specific induction of CD154 is impaired in CD4+ T cells from human immunodeficiency virus-infected patients Journal of Infectious Diseases 189(1): 61-70
Castells, L.; Esteban, J.I.; Bilbao, I.; Vargas, V.; Allende, H.; Ribera, E.; Piron, M.; Sauleda, S.; Len, O.; Pahissa, A.; Esteban, R.; Guardia, J.; Margarit, C. 2006: Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients Antiviral Therapy 11(8): 1061-1070
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332